−1.97USD
−100.70 MUSD
40.08 M
About Oric Pharmaceuticals, Inc.
Sector
CEO
Jacob M. Chacko
Headquarters
South San Francisco
Website
Employees (FY)
100
Founded
2014
ISIN
US68622P1093
FIGI
BBG00BL5SLH5
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ORIC is 9.51 USD — it has decreased by 2.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Oric Pharmaceuticals, Inc. stocks are traded under the ticker ORIC.
Oric Pharmaceuticals, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
ORIC stock is 7.27% volatile and has beta coefficient of 2.37. Check out the list of the most volatile stocks — is Oric Pharmaceuticals, Inc. there?
One year price forecast for Oric Pharmaceuticals, Inc. has a max estimate of 25.00 USD and a min estimate of 15.00 USD.
ORIC earnings for the last quarter are −0.44 USD whereas the estimation was −0.46 USD which accounts for 4.80% surprise. Estimated earnings for the next quarter are −0.48 USD. See more details about Oric Pharmaceuticals, Inc. earnings.
Yes, you can track Oric Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ORIC stock has fallen by 6.67% compared to the previous week, the month change is a 35.22% fall, over the last year Oric Pharmaceuticals, Inc. has showed a 65.39% increase.
ORIC net income for the last quarter is −28.33 M USD, while the quarter before that showed −25.48 M USD of net income which accounts for −11.19% change. Track more Oric Pharmaceuticals, Inc. financial stats to get the full picture.
Today Oric Pharmaceuticals, Inc. has the market capitalization of 657.59 M, it has decreased by 11.67% over the last week.
No, ORIC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ORIC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Oric Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 100.00 employees. See our rating of the largest employees — is Oric Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Oric Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Oric Pharmaceuticals, Inc. stock shows the neutral signal. See more of Oric Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Oric Pharmaceuticals, Inc. future price: according to them, ORIC price has a max estimate of 25.00 USD and a min estimate of 15.00 USD. Read a more detailed Oric Pharmaceuticals, Inc. forecast: see what analysts think of Oric Pharmaceuticals, Inc. and suggest that you do with its stocks.